EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS.
D000928:Antidepressive Agents; D035843:Biomedical Research; D003863:Depression; D003866:Depressive Disorder; D004358:Drug Therapy; D006801:Humans; D007099:Imipramine; D008333:Mandelic Acids; D008660:Metabolism; D009638:Norepinephrine; D010600:Pharmacology; D010624:Phenelzine; D010919:Placebos; D014556:Urine
C475474:3-methoxy-4-hydroxymandelic acid; D000928:Antidepressive Agents; D008333:Mandelic Acids; D010919:Placebos; C037938:mandelic acid; D010624:Phenelzine; D007099:Imipramine; D009638:Norepinephrine
CLINICAL RESEARCH; DEPRESSION; DRUG THERAPY; IMIPRAMINE; MANDELIC ACID; METABOLISM; NOREPINEPHRINE; PHARMACOLOGY; PHENELZINE; PLACEBOS; URINE